[Fulminant acute hepatitis treated by immunologic therapy (author's transl)].
Following the most recent results on immunological pathogenetic mechanism, on which seems to be based the malignant evolution of acute viral hepatitis the AA. have treated a patient affected of acute fulminant hepatitis by means of immunologic therapy with specific globulins anti-HBsAg. The result of this personal experience and the analysis of the data from the literature suggest the opportunity to use specific antibodies (HBsAb) associated with syntomatic and depurative therapies, with obvious limits of single experience.
D000208:Acute Disease; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation; D000918:Antibody Specificity; D005260:Female; D006511:Hepatitis B Antigens / Q000032:analysis; D006525:Hepatitis, Viral, Human / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*
D000914:Antibodies, Viral; D006511:Hepatitis B Antigens
Epatite acuta fulminante trattata con immunoterapia